Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia-Reference-Cited by-同舟云学术

Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia

Author:

Scott Nick¹²,Iser David M³⁴,Thompson Alexander J⁴⁵,Doyle Joseph S¹⁵⁶,Hellard Margaret E¹²³

Affiliation:

1. Centre for Population Health; Burnet Institute; Melbourne Victoria Australia

2. Department of Epidemiology and Preventative Medicine; Monash University; Clayton Victoria Australia

3. Department of Infectious Diseases; Alfred Hospital; Melbourne Victoria Australia

4. Department of Gastroenterology; St Vincent's Hospital Melbourne; Fitzroy Victoria Australia

5. Department of Medicine; The University of Melbourne; Parkville Victoria Australia

6. Victorian Infectious Diseases Service at the Doherty Institute; Melbourne Health; Melbourne Victoria Australia

Funder

Victorian Infectious Diseases Service Special Purpose Fund

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

Reference50 articles.

1. Epidemiology and natural history of HCV infection;Hajarizadeh;Nat. Rev. Gastroenterol. Hepatol.,2013

2. The Kirby Institute HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2014 2014

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Cost effectiveness of hepatitis C direct acting agents;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-03